BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Parkinson's disease clinical trials and catalysts

Active industry-sponsored trials on ClinicalTrials.gov for Parkinson disease: 208 (119 sponsors; 30 newly posted in the last 180 days, 16 stopped in the last 180 days; 21 new-entrant sponsors). Momentum score 10.1, rank 68 of 91 on the disease-area ranking. As of 2026-11-18.

Phase distribution: Early Phase 1 7, Phase 1 34, Phase 2 67, Phase 3 36, Phase 4 2, N/A 62.

Most active sponsors, by phase

SponsorActive trialsBy phaseNew (window)Upcoming readouts
Merck Sharp & Dohme LLC MRK41P3 23, P2 15, NA 1, P1 205
Hoffmann-La Roche4P3 1, P2 310
AstraZeneca AZN3P2 1, P1 1, P3 100
BlueRock Therapeutics BPRE2NA 1, P3 101
NeuroDerm Ltd.2P3 1, P2 100
Annovis Bio Inc. ANVS1P3 100
Biohaven Therapeutics Ltd. BHVN1P3 100
Cerevance1P3 100
Hangzhou PhecdaMed Co., Ltd. new entrant1P3 110
Jazz Pharmaceuticals JAZZ1P3 100
MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals1P3 100
Ono Pharmaceutical Co., Ltd. new entrant1P3 110
Taiho Pharmaceutical Co., Ltd. new entrant1P3 110
Zhejiang Vimgreen Pharmaceuticals, Ltd. new entrant1P3 110
InSightec9NA 910
AbbVie ABBV8NA 803
iRegene Therapeutics Co., Ltd.5P1 2, P2 301
AskBio Inc3P2 2, NA 100
Boston Scientific Corporation BSX3NA 300
MODAG GmbH new entrant3EARLY_P1 332
Abbott Medical Devices2NA 200
AC Immune SA ACIU2EARLY_P1 1, P2 101
Bayer2P2 1, NA 100
Bial - Portela C S.A.2NA 200
BioNTech SE BNTX2P1 1, P2 100

New-entrant sponsors: Hangzhou PhecdaMed Co., Ltd., Ono Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., Zhejiang Vimgreen Pharmaceuticals, Ltd., MODAG GmbH.

Recently stopped trials

Upcoming trial readouts (next 90 days)

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-11-28 est.P2TrueBinding, Inc.NCT06773962 A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's DiseaseParkinson's Disease (PD)active not recruiting62
2026-12 est.P2iRegene Therapeutics Co., Ltd.NCT07028632 The Safety, Feasibility and Efficacy of NouvNeu001 for Parkinson's DiseaseParkinson Disease (PD)not yet recruiting30
2026-12 est.P1/P2EicOsis Human Health Inc.NCT07142044 Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study)Parkinson's Disease (PD)recruiting18
2026-12-31 est.P2Hillhurst Biopharmaceuticals, Inc.NCT07005180 Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's DiseaseParkinson Diseaserecruiting36

Readouts in the last 180 days

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-09-10 est.P1/P2Shanghai Vitalgen BioPharma Co., Ltd.NCT06480461 A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Patients With Parkinson's DiseaseParkinson's Diseaseactive not recruiting39
2026-09-02P2Il-Yang Pharm. Co., Ltd.NCT04691661 Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's DiseaseParkinson Diseaseactive not recruiting43
2026-08-10P2BioArctic ABNCT06671938 Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System AtrophyParkinson Disease; Multiple System Atrophycompleted38
2026-08 est.P3CerevanceNCT06553027 To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor ComplicationsParkinson Diseaseactive not recruiting330
2026-06-17P1/P2Capsida Biotherapeutics, Inc.NCT07011771 A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's DiseaseGBA1 Parkinson Diseasewithdrawn

Landscape counts: ClinicalTrials.gov, industry lead sponsors, active statuses, via the free hosted BioCatalystFeed MCP tool condition_landscape (query "Parkinson disease"); readouts matched by condition text. Registry counts only; not a forecast.

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.